I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Delforge, Michel
204
results:
OpenAccess-fulltext X
Search for persons
X
Languages
english (189)
french (5)
Sorted by: Relevance
Sorted by: Year
?
1
Rethinking the reimbursement of innovative medicines in onc..:
Piccart, Martine
;
Vansteenkiste, Johan
;
Prenen, Hans
...
boreal:279022. , 2023
Link:
http://hdl.handle.net/20..
?
2
P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL..:
Moreau, Philippe
;
van de Donk, Niels W.C.J
;
Delforge, Michel
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431245/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
3
P904: LOCOMMOTION: A PROSPECTIVE, OBSERVATIONAL, MULTINATIO..:
Moreau, Philippe
;
Weisel, Katja
;
De Stefano, Valerio
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431124/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
4
Impact of newly diagnosed extramedullary myeloma on outcome..:
Gagelmann, Nico
;
Eikema, Dirk-Jan
;
Koster, Linda
...
info:eu-repo/semantics/altIdentifier/doi/10.1111/ejh.13981. , 2023
Link:
https://hal.univ-lille.f..
?
5
P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A..:
Sidana, Surbhi
;
Moreau, Philippe
;
Garfall, Alfred
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431083/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
6
Outcome of second primary malignancies developing in multip..:
Avivi, Irit
;
Vesole, David H
;
Davila-Valls, Julio
...
info:eu-repo/semantics/altIdentifier/pmid/37686635. , 2023
Link:
https://hdl.handle.net/1..
?
7
Comparative Efficacy of Teclistamab Versus Current Treatmen..:
Moreau, Philippe
;
van de Donk, Niels W. C. J
;
Delforge, Michel
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129954/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
P905: PATIENT REPORTED OUTCOMES IN TRIPLE CLASS EXPOSED, RE..:
Delforge, Michel
;
Patel, Krina
;
Eliason, Laurie
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430925/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIP..:
Hultcrantz, Malin
;
Kleinman, David
;
Vij, Ravi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429714/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS..:
Patel, Krina
;
Rodríguez-Otero, Paula
;
Manier, Salomon
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428360/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
11
Rethinking the reimbursement of innovative medicines in onc..:
Piccart, Martine
;
Vansteenkiste, Johan
;
Prenen, Hans
...
boreal:279022. , 2023
Link:
http://hdl.handle.net/20..
?
12
Case report: Two sisters with light-chain cardiac amyloidos..:
Cappuyns, Sarah
;
Verbesselt, Matthias
;
Van De Bruaene, Alexander
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922710/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
13
Case report: Chronic neutrophilic leukemia associated with ..:
Vermeersch, Gaël
;
Delforge, Michel
;
Havelange, Violaine
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768602/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
14
Addition of elotuzumab to lenalidomide and dexamethasone fo..:
Dimopoulos, Meletios A
;
Richardson, Paul G
;
Bahlis, Nizar J
...
info:eu-repo/semantics/altIdentifier/pmid/35550060. , 2022
Link:
https://hdl.handle.net/2..
?
15
Health-related quality of life with idecabtagene vicleucel ..:
Delforge, Michel
;
Shah, Nina
;
Miguel, Jesús San F
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864645/. , 2022
Link:
http://www.ncbi.nlm.nih...
1-15